Share
PDFCommentary
The scope of patient, healthcare professional and healthcare systems responsibilities to reduce the carbon footprint of inhalers: a response to commentaries
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
Other content recommended for you
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Green prescribing is good, but patients do not have a duty to accept it
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
- Inhaler devices for asthma
- Inhalers: to switch or not to switch? That is the question
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
- The president speaks: prevention is best: lessons from protecting the ozone layer